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Abstract
Background: Low-abundance proteins are difficultly observed on the two-dimensional gel electrophoresis (2-DE)
maps of urine proteome, because they are usually obscured by high-abundance proteins such as albumin and
immunoglobulin. In this study, a novel fractionation method was developed for enriching low-abundance proteins
by removing high-abundance proteins and progressive elution with salts of various concentrations.
Results: Stepwise weak anion exchange (WAX) chromatography, which applied DEAE-Sephacel resin with non-
fixed volume elution, was used to fractionate urine proteome prior to performing 2-DE. Urine proteome was
separated into four fractions by progressively eluting the column with 0 M, 50 mM, 100 mM, and 1 M NaCl
solutions. Most of the heavy and light immunoglobulin chains appeared in the eluent. After the high-abundance
proteins were removed, various low-abundance proteins were enriched and could be easily identified. The
potential of this method for obtaining diversified fractionations was demonstrated by eluting the column
separately with Na2SO4 and MgCl2 solutions. The 2-DE maps of the fractions eluted with these different salt
solutions of identical ionic strength revealed markedly different stain patterns.
Conclusion: The present study demonstrated that this fractionation method could be applied for purposes of
enriching low-abundance proteins and obtaining diversified fractionations of urine, and potentially other
proteomes.
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Background
Two-dimensional gel electrophoresis (2-DE) is a power-
ful technique for resolving a complex protein mixture.
The analysis of urine proteins by 2-DE offers the poten-
tial for diagnosing and monitoring the progression of
various diseases [1-5]. For example, analyses of urine
proteins for the identification of disease biomarkers
have been applied in bladder cancer [6,7], lung cancer
[8], ovarian cancer [9], prostate cancer [10], membra-
nous nephropathy [11], diabetic nephropathy [12],
nephritic syndrome [13], and glomerular nephrotoxicity
[14]. Although several 2-DE maps of human urine have
been published [15-17], the resolution of these maps
remains insufficient s, and the demonstration of whole
proteins in human urine remains a challenge. Immuno-
globulin heavy and light chain proteins, as well as other
high-abundance proteins, often obscure low-abundance
proteins on 2-DE maps. An effective way to increase the
resolution of urine proteome is to carry out a fractiona-
tion procedure prior to performing the 2-DE analyses.
Certain fractionations have been widely used prior to
2-DE analysis in order to obtain more comprehensive
information. For example, immunoaffinity subtraction
chromatography [17], ligand beads [18], preparative
electrophoresis and 2-DE [19], cation exchange chroma-
tography in combination with a batch-absorption
method [20], and finally, a commercially manufactured
protein depletion kit to remove the six most abundant
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haptoglobin, immunoglobulin G, immunoglobulin A,
and alpha-1 antitrypsin) [21] have all been utilized for
this purpose.
There are many methods available for protein separa-
tion, and include, ammonium sulfate precipitation, gel-
filtration, hydrophobic interaction chromatography, and
ion exchange chromatography. Fractionation by ammo-
nium sulfate precipitation depends on the solubility of
protein. When the concentration (ionic strength) of the
salt increases, solubility of the protein reduces. At a
higher ionic strength, more proteins will be precipitated
from the solution. Due to the inadequate protein resolu-
tion of ammonium sulfate precipitation, this method is
usually only used in preliminary protein separation.
While gel-filtration separates proteins based on the size
of proteins, its main disadvantage is a limited loading
capacity and low resolution associated with diffusion and
turbulence. On the other hand, protein separation by
hydrophobic interaction chromatography relies on differ-
ences in hydrophobic groups on the surface of solute. In
this method, the hydrophobic groups of proteins bind the
hydrophobic groups on the surface of an insoluble
matrix. Further, ion exchange chromatography depends
on charge-charge interaction between the fluid body pro-
teins and the charges of the resin. In anion exchange
chromatography, the binding ions have negative charge
and the immobilized functional groups have positive
charge. Once the solutes are bound to the gel, the col-
umn is washed with a starting buffer and the bound
molecules are eluted off using a salt solution with various
ionic strength. There are two main elution methods in
chromatography: continuous gradient elution and step-
wise isocratic elution. However, under equal volume of
eluent, the best resolution can be obtained by using con-
tinuous gradient elution rather than stepwise isocratic
elution. A low-abundance protein which is diluted in dif-
ferent fractions will reduce the possibility of a successful
identification. To circumvent this problem, a stepwise,
non-fixed volume, isocratic elution weak anion exchange
(WAX) chromatography fractionation approach was
investigated in this study. This modified WAX fractiona-
tion was comprised of four stepwise isocratic elusions. At
each isocratic ionic strength, the elution process was con-
tinued until protein failed to be detected in the eluent.
The aims of this study were to establish 2-DE maps with
fine resolution and to enrich low-abundance proteins,
thereby providing a platform for identification of poten-
tial disease biomarkers.
Materials and methods
Collection of urine
Urine samples were collected from 11 healthy males and
9 females between the ages of 18 and 54 years. Subjects
with renal disorders or those being administered medi-
cation during the sample collection period were
excluded. None of the females were menstruating at the
time of sample collection. A 100 mL midstream urine
sample was collected in the morning for each individual,
and the samples were then combined together and sup-
plemented with protease inhibitor cocktail to avoid pro-
teolysis. Samples were centrifuged at 12,000 rpm at 4°C
to remove cell debris and insoluble solids. The final
supernatants (2L) were then loaded to a Stirred Ultrafil-
tration Cell 8400 (Millipore, Billerica, MA, USA) and
YM5 membrane (5000 molecular weight cut-off) to con-
centrate the solution and remove small interference
molecules. The concentrated urine samples had a final
volume of 50 ml, and were stored at -80°C until further
use. This protocol was approved by the Institute Review
Board (Approval No. B09601020).
Fractionation of urine proteome by non-fixed volume
stepwise WAX
A column (5 cm × 10 cm) packed with 50 gram DEAE-
Sephacel (a weak anion exchanger from GE Healthcare)
was equilibrated five times with 50 mM Tris-HCl buffer
prior to use. Twenty ml of concentrated urine samples
were dialyzed overnight at 4°C with 50 mM Tris-HCl
buffer (pH 8.0, 1 mM EDTA, 20 mM DTT). After
removing the precipitate formed during dialysis by cen-
trifugation (8000 rpm), the sample was added to the col-
umn. First, the column was eluted by 3000 ml of
50 mM Tris-HCl buffer without salt at a flow rate of
40 ml/hr until no protein was detected in the eluent by
Bradford dye assay. This process is distinct from fixed
volume elution, in which some proteins could present in
more than one fraction. A total of 3000 ml of combined
eluent was collected and concentrated to a volume of
50 ml by using a Stirred Ultrafiltration Cell 8400 and a
YM5 membrane. This sample was referred to as
“unbound”. Next, a solution of 50 mM NaCl/50 mM
Tris-HCl buffer was used to elute the column, again
until no protein was detected in the eluent, and a total
of 8000 ml solution was collected and concentrated to
obtain the 2
nd fraction (referred to as “NaCl-1”). A total
of 4500 ml of 100 mM NaCl/50 mM Tris-HCl buffer
was collected for the next elution, followed by concen-
tration to obtain fraction NaCl-2. A 4000 ml of 1 M
NaCl/50 mM Tris-HCl buffer was collected for the last
elution using to obtain fraction NaCl-3. The whole elu-
tion process for obtaining fractionations of urine protein
was carried out in a 4°C cold chamber to maintain the
stability of proteins.
Protein precipitation by trichloroacetic acid/acetone
The urine protein mixture in the supernatant was preci-
pitated out overnight at -20°C by triple the volume of
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[3]. After centrifugation at 8000 rpm for 30 min at
4°C, the supernatant was discarded. The pellet was
rinsed three times in cold acetone containing 20 mM
DTT and air-dried, and subsequently resuspended
overnight at 4°C in a rehydration buffer purchased
from Bio-Rad (6 M urea, 2 M thiourea, 0.5% CHAPS,
0.5% IPG buffer, 20 mM DTT, 0.002% bromophenol
blue). The protein contents were determined using a
2-D Quant Kit (GE Healthcare).
Two-dimensional gel electrophoresis
The first dimension electrophoresis (isoelectric focusing)
was performed on a Bio-Rad PROTEAN IEF Cell at
20°C with a current limit of 50 A per strip. A sample
was dissolved in rehydration buffer (as described above)
and applied on a IPG strip in a strip holder. Every
11-cm pI 4-7 IPG strip (Immobiline DryStrip) was rehy-
drated at 50 V for 12 h, then focused according to the
preset program (200 V (1.5 h), 500 V (1 h), 1,000 V
(1 h), 4,000 V (1 h), 8,000 V (2 h)) until the total Vh
reached 19,960. On the other hand, every 11-cm pI
3-10NL IPG strip was rehydrated at 30 V for 12 h, then
focused according to the preset program (200 V (1.5 h),
500 V (1 h), 1,000 V (1 h), 4,000 V (1 h), 8,000 V (3 h),
until the total Vh reached 27,960.
After isoelectric focusing, the strip was removed and
equilibrated for 10 min in a 5 ml buffer (50 mM Tris-
HCl, pH 8.8, 6 M urea, 30% glycerol, 2% SDS, 0.01%
bromophenol blue) containing 1% (w/v) DTT, then
transferred to another 5 ml equilibration buffer contain-
ing 2.5% (w/v) iodoacetamide for an additional 10 min.
The equilibrated strip was placed on the top of a SDS-
PAGE gel (12.5%), sealed with 0.5% agarose, followed by
the running of a second dimension electrophoresis at
150 V for 6.5 h. The electrophoretic unit used for the
second dimension electrophoresis was an SE 600 Ruby
(Hoeffer).
Protein spot identification by LC-MS/MS
In-gel Digestion
A 1 mm × 1 mm piece of protein at the spot of interest
was excised and placed into a microcentrifuge tube.
A 100 μlof 50 mM DTT in 25 mM ammonium bicarbo-
nate (pH 8.5) was added to the tube which was shaken
for 1 h at 37°C. After removing excess DTT in the
supernatant, 100 μl of 100 mM Iodoacetamide (IAA) in
25 mM ammonium bicarbonate (pH 8.5) was added to
the tube which was shaken for 30 min at RT in the
dark. The excess IAA in the supernatant was removed.
Next, 100 μl of 50% acetonitrile in 25 mM ammonium
bicarbonate buffer (pH 8.5) was added, and the gel piece
was soaked for 15 minutes followed by a complete
removal of the buffer. The destaining process was
carried out two or more times depending on the inten-
sity of the dye. The gel piece was soaked in a 100 μlo f
100% acetonitrile for 5 minutes and dried by SpeedVac
to remove the remaining acetonitrile. After drying,
0.1 μg of trypsin in 10 μl 25 mM ammonium bicarbo-
nate (pH 8.5) was added to the gel piece. One hour
later, another 100 μl 25 mM ammonium bicarbonate
was added and digestion was run for 16 h at 37°C.
Following, 50 μl of 5% TFA in 50% acetonitrile was
added to quench the trypsin digestion. The solution was
sonicated for 10 second to release the tryptic peptides
from the gel. The peptide solution was concentrated for
the following LC-MS/MS analysis.
LC-MS/MS analysis
The above peptide mixture was subjected to a CapLC
system (Waters, Milford, MA,) using a capillary col-
umn (75 um i.d., 10 cm in length, C SUN, Taiwan)
with a linear gradient from 5% to 50% acetonitrile con-
taining 0.1% formic acid for a total duration of 46 min-
utes. The separated peptides were analyzed online
under positive survey scan mode on a nano-ESI Q-
TOF (Micromass, UK) instrument. The scan range was
from m/z 400 to1600 for MS and m/z 50 to 2000 for
MS/MS. The raw data was processed into a text file
format of PKL with MassLynx 4.0 (subtract 30%,
smooth 3/2 Savitzky Golay and center three channels
80% centroid).
Database search
For purposes of protein identification, the PKL files gen-
erated from MS/MS spectra were uploaded to the MAS-
COT search engine v2.2 (Matrix Science, UK) (http://
www.matrixscience.com). The parameters selected for
searching the database were as follows: a) protein data-
base was set to NCBInr, b) taxonomy was set as human,
c) a single trypsin missed cleavage was allowed, d) the
mass tolerance was set to be 0.3 Da for both precursor
and product ions, e) carbamidomethyl (C) was chosen
as a fixed modification, f) deamidated (NQ), oxidation
(M), Carbamidomethyl (K) and Carbamidomethyl
(N-term) were chosen for variable modifications, and
finally, g) the data was formatted into Micromass (.pkl)
and ESI-QUAD-TOF was the chosen instrument. Pro-
teins with scores above the significance threshold (p <
0.05) were identified. All significant hits have at least
two matched peptides.
Western blot analysis
Either 1-D or 2-D gel was transferred to a PVDF mem-
brane (Millipore) for 1.5 h at 400 mA using Transphor
TE 62 (Hoeffer). The membrane was then blocked over-
night by a blocking solution (50 mM Tris-HCl, pH 8.0,
0.25% gelatin, 150 mM NaCl, 5 mM EDTA, 0.05%
Tween 20). An antibody with appropriate dilution was
added to the membrane and incubated at room
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anti-RBP4 polyclonal antibodies were purchased from
ProteinTech Group, USA. Rabbit anti-HP polyclonal
antibody was purchased fromR o c k l a n d ,U S A .M o u s e
anti-b-actin monoclonal antibody was purchased from
Sigma-Aldrich, USA. Mouse anti-Immunoglobulin
monoclonal antibody was purchased from GenWay Bio-
tech, USA. The membrane was washed three times in
PBST (10 mM NaH2PO4, 130 mM NaCl, 0.05% Tween
20), then probed with the second Ab (goat anti-mouse
IgG and horseradish peroxidase conjugate, 1:10,000 in
blocking solution) for 1 h. After it was washed three
times with PBST, the enzyme activity on the blot was
visualized through chemiluminesence by adding ECL
Western Blotting Reagents (Pierce).
Results and Discussion
2-DE maps of urine proteome
A 2000 ml urine sample was collected from 20 healthy
people. In order to eliminate individual differences, the
samples were pooled together and concentrated by Stir-
red Ultrafiltration Cell 8400. The proteins were precipi-
tated by 10% TCA/Acetone after dialysis.
An equal amount of 50 μg per gel was resolved in
2 - D Eu s i n gI P Gs t r i p s( p I4 - 7a n dp I3 - 1 0 N L ) .T h e
protein spots were visualized with silver stain and were
excised for subsequent in-gel digestion and identifica-
tion by LC-MS/MS. A total of 350 protein spots were
detected in Figure 1A and a total of 220 spots were
detected in Figure 1B by comparative analysis using
PDQuest 2-D software (version 7.1.1). A direct 2-DE
analysis of a complex protein sample can encounter
resolution problems, and not all proteins can be
detected on a 2-DE map. The difference in resolution
could explain why more protein spots were detected in
Figure 1A than in Figure 1B. The protein identification
was carried out by LC-MS/MS. The spots N33 ~ N36,
identified in Figures 1A and 1B, were immunoglobulin
heavy and light chain proteins which were also listed
in Table 1. Mouse anti-human immunoglobulin mono-
clonal antibody was also used for 2-D immunoreactiv-
i t ya n a l y s i st oc o n f i r mt h ed a t aa ss h o w ni nF i g u r e s1 C
and 1D. The results clearly indicate that immunoglo-
bulin heavy and light chain proteins are high-abundant
in urine, which obscure t h ep r e s e n c eo ft h el o w -
abundance proteins. Thus, it is necessary to remove
the abundant proteins to enrich the low-abundance
proteins. The application of nProtein A Sepharose (GE
Healthcare) was widely used for removing immunoglo-
b u l i nf r o map r o t e i nm i x t u r e .A na t t e m p tt or e m o v e
immunoglobulin proteins in urine by nProtein A
Sepharose was not successful (results reported in the
additional file 1: Supplemental section and Additional
file 2: figure S1).
Fractionation of urine proteome by non-fixed volume
stepwise WAX with NaCl solutions
Ion exchange chromatography depends on charge-
charge interactions between the proteins of a sample
and the charges immobilized on the resin. In anion
exchange chromatography the binding ions are nega-
tively charged and the immobilized functional groups
are positively charged. Once the solutes are bound to
the gel, the column is washed in a starting buffer to
equilibrate, then the bound molecules are eluted off in a
stepwise manner using a salt solution with increasing
ionic strength. At low ionic strengths, competition for
charged proteins on gel resin is at a low level, therefore
they are bound strongly on gel resin. When the ionic
strength increases, so does the competition, and in turn,
the affinity between proteins and gel resin decreases.
The end result is more bound proteins being released
from the gel resin. Thongboonkerd et al. used SP
Sepharose Fast Flow Bead (a cationic ion exchange
chromatography) to enrich the basic proteins in urine
such as eosinophil-derived neurotoxin and interferon
alpha [20]. This study used stepwise elution anion
exchange chromatography for the fractionation of urine
proteins and the enrichment of low-abundance proteins.
The recovery rates of proteins were between 72.1% and
74.2%. The non-fixed volume stepwise elution method
offers the potential of high resolution in preparative
applications. Ideally, the non-fixed volume stepwise elu-
tion can eliminate the overlapping distribution of pro-
teins in two neighboring fractions. The 2-DE maps of
the four fractions of total urine protein eluted by NaCl
(fraction Unbound, fraction NaCl-1, fraction NaCl-2,
and fraction NaCl-3) were shown in Figure 2A to 2D.
The protein spots were visualized with silver stain
which is a sensitive method for the appearance of pro-
tein with a limitation on dynamic range. In practice, the
disadvantage for making more protein spots visible is
the resulting smear around some spots. Three replicates
were done for the 2D electrophoresis of each urine frac-
tions. By comparative analysis using PDQuest 2-D soft-
ware (version 7.1.1) a total of 40 ± 3.6 (average ± SD)
protein spots (range 36-43) were detected in Figure 2A
for fraction Unbound, a total of 278 ± 3.2 spots (range
274-280) were detected in Figure 2B for fraction NaCl-
1, a total of 222 ± 8.3 spots (range 213-229) were
detected in Figure 2C for fraction NaCl-2, and a total of
68 ± 5.6 spots (range 62-73) were detected in Figure 2D
for fraction NaCl-3. Comparing with the 2-DE map of
total urine protein without pre-fractionation, the num-
ber of spots recognized by PDQuest 2-D software was
significantly higher. The additional file 1: Supplemental
section and Additional file 3: figure S2A-S2D show the
corresponding 2-DE maps of the fractions run by pI
3-10NL. The very different silver staining patterns of the
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of urine proteins was achieved. Most of the high-abun-
dance proteins including immunoglobulin heavy and
light chain proteins, appeared in Figure 2A. The low-
abundance proteins were enriched in fraction NaCl-1 to
fraction NaCl-3 (as shown in Figure 2B to 2D). The
identities of 32 protein spots (N1 ~ N32) analyzed by
LC-MS/MS after excision and in-gel digestion were
reported in Table 1. The major protein spots identified
in fraction Unbound were immunoglobulin heavy
and light chain and prostaglandin H2 D-isomerase.
When a mouse monoclonal antibody against human
immunoglobulin was incubated in either total urine pro-
teins versus the four fractions, immunoreactivities were
present in total urine protein but only in fraction
Unbound as shown in Figure 3B. In unison, it has been
shown that the above fractionation method is effective
in separating immunoglobulin heavy and light chain
proteins from other urine proteins.
Some protein spots identified in fraction NaCl-1
and fraction NaCl-2 have several isoforms including,
zn-alpha-2-glycoprotein (ZAG), inter-alpha-trypsin inhi-
bitor family heavy chain-related protein (IHRP), retinol
binding protein 4 (RBP4), heparan sulfate proteoglycan
KD
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95
72
55
43
34
26
Immunoglobulin 
light chain
Immunoglobulin 
heavy chain
B
pI3 pI 10 pI 4p I 7
A
D C
Immunoglobulin 
heavy chain
Immunoglobulin 
light chain
Immunoglobulin 
heavy chain
Immunoglobulin 
light chain
Figure 1 Two-DE maps of urine proteome of healthy people. (A) A total of 350 protein spots were detected at pI 4-7, and (B) a total of 220
spots were detected at pI 3-10NL by comparative analysis with PDQuest 2-D software. (C) 2-D western blot analysis immunoglobulin of total
urine protein (pI 4-7) (D) 2-D western blot analysis immunoglobulin of total urine protein (pI 3-10NL).
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Page 5 of 10(HSPG), mannan-binding lectin-associated serine pro-
tease-2 (MASP-2), mannose binding lectin (MBL) and
alpha-1-microglobulin/bikunin precursor (Figure 2B and
2C). In order to confirm the proteomic results, western
blot analysis of some urine proteins was carried out.
When a mouse monoclonal antibody of anti-human
ZAG was incubated with total urine protein and the
four fractions, immunoreactivities were identified in
total urine protein but only in one of 4 fractions (frac-
tion NaCl-1) as shown in Figure 3C. When a mouse
antibody anti-human RBP4 was used, a similar phenom-
ena was obtained as shown in Figure 3D. The results
indicated that the stepwise elution DEAE-Sephacel
anion exchange chromatography was effective in remov-
ing abundant proteins from total urine protein for the
enrichment of low-abundance proteins.
Due to the presence of isoforms, only 15 proteins
were identified from the 32 protein spots. It was likely
that many of the proteins went through protein modifi-
cation such as glycosylation or phosphorylation, present-
ing continuous spots on the 2-DE map. Each of the five
proteins including ZAG, IHRP, RBP4, MASP-2, and
HSPG with different pI, molecular weights, or isoforms
appeared on the 2-DE map as more than one spot. ZAG
(spot N4 ~ N7) is a glycoprotein with a molecular mass
~41 kDa. It appears in most body fluid, such as sweat,
Table 1 Summary of protein spots of healthy urine identified by LC-MS/MS
Spot
number
Protein name NCBI acc.no Calculate
Mr/pI
Peptide
matched
Sequence
covered %
MASCOT
score
N1 Chain G, Gelsolin G4-G6 actin complex 1H1V_G 36.3/5.0 15 56 587
N2 Chain G, Gelsolin G4-G6 actin complex 1H1V_G 36.3/5.0 11 42 430
N3 keratin 10 XP_001169450 58.7/5.13 16 23 541
N4 Zn-alpha2-glycoprotein CAA42438 34.7/5.71 10 20 249
N5 Zn-alpha2-glycoprotein CAA42438 34.7/5.71 11 41 357
N6 Zn-alpha2-glycoprotein CAA42438 34.7/5.71 11 30 317
N7 Zn-alpha2-glycoprotein CAA42438 34.7/5.71 19 34 458
N8 mannose-binding lectin 2 NP_006807 40.2/6.46 8 9 187
N9 mannose-binding lectin 2 NP_006807 40.2/6.46 10 25 251
N10 mannose-binding lectin 2 NP_006807 40.2/6.46 13 23 262
N11 inter-alpha-trypsin inhibitor family heavy chain-
related protein
BAA07602 103/6.51 10 9 453
N12 inter-alpha-trypsin inhibitor family heavy chain-
related protein
BAA07602 103/6.51 18 11 456
N13 alpha-1-microglobulin/bikunin precursor NP_001624 38.9/5.95 6 7 89
N14 alpha-1-microglobulin/bikunin precursor NP_001624 38.9/5.95 11 28 308
N15 complex-forming glycoprotein HC 0801163A 20.4/5.84 24 50 348
N16 inter-alpha-trypsin inhibitor family heavy chain-
related protein
BAA07602 103/6.51 7 8 261
N17 inter-alpha-trypsin inhibitor family heavy chain-
related protein
BAA07602 103/6.51 12 11 286
N18 inter-alpha-trypsin inhibitor family heavy chain-
related protein
BAA07602 103/6.51 8 7 296
N19 prostaglandin H2 D-isomerase NP_000945 21.0/7.66 10 28 239
N20 heparan sulfate proteoglycan 2 XP_001099299 468/6.06 1 17 260
N21 heparan sulfate proteoglycan 2 XP_001099299 468/6.06 1 22 304
N22 mannan-binding lectin-associated serine protease-2 CAA67050 75.6/5.42 8 25 238
N23 mannan-binding lectin-associated serine protease-2 CAA67050 75.6/5.42 1 2 82
N24 retinol binding protein 4 1RBP 20.9/5.27 14 20 171
N25 retinol binding protein 4 1RBP 20.9/5.27 15 33 560
N26 immunoglobulin kappa light chain VLJ region BAC01709 29.0/5.46 22 31 741
N27 immunoglobulin kappa light chain VLJ region BAC01762 28.4/7.53 2 9 84
N28 immunoglobulin heavy chain CAC10254 39.7/8.3 11 17 240
N29 immunoglobulin heavy chain CAC10254 39.7/8.3 17 16 303
N30 vitelline membrane outer layer 1 isoform 1 NP_872372 21.5/4.9 3 24 99
N31 beta globin chain AAA35952 18.9/6.28 2 13 99
N32 beta globin chain ACF16774 11.4/6.9 5 48 192
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Page 6 of 10urine, blood, and cerebrospinal fluid. RBP4 (spot N24,25)
is a carrier protein that transports retinol from the liver
to the peripheral tissues and has been reported as a
potential biomarker for glomerular disease [22]. As most
reports of RBP4 in urine are related to disease, the signif-
icance of its existence in the urine of a healthy person is
unknown. IHRP (spots N12, N16 ~ N18) is identified as
an acute phase protein in animals that may function as
an anti-inflammatory protein [23]. HSPG (spot N20, 21)
have a potential role in glomerular filtration. Further,
MBL (spot N8 ~ N10), a collagen-like serum protein, is a
key component of innate immunity, which binds to
carbohydrates on pathogens and mediates lectin-depen-
dent activation of the complement pathway [24]. MASP-
2 (spot N22, 23) is an enzyme of the innate immune sys-
tem, which is activated when one of these proteins recog-
nizes microorganisms and subsequently cleaves
complement factors C4 and C2, and initiates the activa-
tion of the complement system [25]. All five proteins dis-
cussed above have direct links with immune response
and inflammation, and have all been previously identified
by Adachi et al. who used one-dimensional sodium dode-
cyl sulfate polyacrylamide gel and reverse phase high-per-
formance liquid chromatography [26]. Although a large
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Figure 2 2-DE maps of fractions of urine proteome of healthy people obtained by non-fixed volume stepwise elution DEAE-Sephacel
anion exchange chromatography.( p I 4-7) (A) unbound Proteins in fraction (B) Proteins in fraction NaCl-1 obtained by elution with 50 mM
NaCl. (C) Proteins in fraction NaCl-2 obtained by elution with 100 mM NaCl. (D) Proteins in fraction NaCl-3 obtained by elution with 1 M NaCl.
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Page 7 of 10number of urine proteins were identified in this prior
study (n = 1543), mass spectrometry analysis could not
identify protein isoforms and possible post-translation
modification. The strength of 2-DE analysis comes from
both the qualitative and quantitative protein information
revealed on the 2-DE maps. It is anticipated that poten-
tial disease biomarkers could be identified by detecting
the qualitative and quantitative difference between the 2-
DE maps of fractions of urine protein of patients and
normal people using LC-MS/MS and western blotting
analysis. In this study, DEAE-Sephacel was used as the
gel resin in stepwise elution anion exchange chromato-
graphy with clean separation to fractionate total urine
protein and enrich low-abundance proteins with
encouraging results.
Conclusions
The results demonstrated that non-fixed volume, step-
wise elution, weak anion exchange chromatography with
clean separation using DEAE-Sephacel as gel resin was
an effective approach for the fractionation of total urine
protein and the enrichment of low-abundance proteins.
Four fractions of total urine protein were obtained by
stepwise elution of the column, first without NaCl until
no protein was detected in the eluting solution, followed
by 50 mM NaCl solution until no protein was detected
in the eluting solution. The next two fractions were
obtained by eluting with 100 mM NaCl solution and
1 M NaCl solution, respectively. The 2-DE maps of the
four fractions have been established. Identification of 32
protein spots by LC-MS/MS after excision and in-gel
digestion have been carried out. Most of the immuno-
globulin heavy and light chain proteins, which are abun-
dant proteins in urine, only appeared in one of the
fractions. Western blot analysis of immunoglobulin,
ZAP, and RBP4 have been carried out to confirm the
proteomic results. Identification of more protein spots
are being carried out to better understand the whole
scope of the urine proteins. This fractionation method is
robust for the removal of high-abundance proteins, and
can provide distinct fractionations for a more compre-
hensive profiling of protein expression. Although a large
number of urine proteins could be identified by using
the LC-MS/MS method alone, the MS analysis could
not identify protein isoforms and possible post-transla-
tion modification. Overall, the non-fixed volume WAX
fractionation coupled with the downstream 2-DE analy-
sis can provide a more comprehensive display of differ-
ential proteins and is potentially useful for the
identification and quantitation of protein isoforms and
the detection of low-abundant proteins. Targeted MS
screening approaches with sensitive detection and accu-
rate quantification, such as multiple reaction monitoring
(MRM), will be carried out to evaluate the differential
proteins for the identification of potential disease
biomarkers.
The solutions of two other salts, Na2SO4 and MgCl2,
were also used for the elution. The method and result
were reported in the additional file 1: Supplemental sec-
tion and Additional file 4: figure S3. The 2-DE maps of
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Figure 3 Western blot analysis of immunoglobulins, zinc-alpha-2-glycoprotein and retinol-binding protein 4 in urine proteome and
fractions of urine proteome of healthy people. (A) CBR staining patterns of total urine protein (1), fraction Unbound (2), fraction NaCl-1 (3),
fraction NaCl-2 (4) and fraction NaCl-3 (5). (B) Immunoreactivity to mouse anti-human immunoglobulin antibody. Two bands, indicating
immunoglobulin heavy and light chain, appeared only in 2 (fraction Unbound) and total urine protein. (C) Immunoreactivity to mouse anti-
human zinc-alpha-2-glycoprotein antibody. The band appeared only in 3 (fraction NaCl-1) and total urine protein. (D) Immunoreactivity to mouse
anti-human retinol-binding protein 4 antibody. The band appeared only in 3 (fraction NaCl-1) and total urine protein.
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tion possessing the same ionic strengths showed signifi-
cantly different stain patterns. The results demonstrated
the potential applications of this fractionation method
using different salts for achieving diversified fractiona-
tion of human urine and enrichment of low-abundance
proteins. It is believed that this method could be applied
to the enrichment of low-abundance proteins in other
body fluids such as serum, tear, saliva, cerebrospinal
fluid, synovial fluid, cells, and tissues.
Wu et al. had reported a novel method for establish-
ing a monoclonal antibody bank [27]. Applying complex
antigens for mouse immunization and using 1-DE and
2-DE for immunoreactivity to identify monoclonal anti-
bodies, a large number of pure monoclonal antibodies
have been isolated. In this study, the developed stepwise
elution DEAE-Sephacel anion exchange chromatography
was effective in obtaining clean fractionations of urine
proteins and enrichment of low-abundance proteins.
A combination of both methods could offer a potentially
promising way to establish a complete monoclonal anti-
body bank of urine proteome. Immunization with each
fraction of urine proteins will be carried out to generate
antibodies which will be separated into many pure
monoclonal antibodies utilizing the method of Wu et al.
The establishment of monoclonal antibody bank of
urine proteome and the subsequent preparation of anti-
body chips of disease biomarkers could be used for sim-
ple and expedited disease screening.
Additional material
Additional file 1: Supplemental Section. Three additional experiments:
1. Separation of immunoglobulin in urine proteome by nProtein A
Sepharose, 2. 2-DE maps for pI 3-10, 3. Fractionation of urine proteome
by non-fixed volume stepwise WAX with Na2SO4, and MgCl2 solutions.
Additional file 2: Figure S1. Separation of immunoglobulin from urine
of healthy people by nProtein A Sepharose. (A) Urine proteins not
adsorbed to the gel resin. (B) Urine proteins adsorbed to the gel resin.
The presence of immunoglobulin heavy and light chain proteins on both
maps indicates that only partial removal of immunoglobulins was
achieved by nProtein A Sepharose.
Additional file 3: Figure S2. 2-DE maps of fractions of urine proteome
of healthy people obtained by non-fixed volume stepwise elution DEAE-
Sephacel anion exchange chromatography. (pI 3-10NL) (A) Unbound
proteins in fraction (B) Proteins in fraction NaCl-1 obtained by elution
with 50 mM NaCl. (C) Proteins in fraction NaCl-2 obtained by elution
with 100 mM NaCl. (D) Proteins in fraction NaCl-3 obtained by elution
with 1 M NaCl.
Additional file 4: Figure S3. Comparison of 2-DE maps of fractions of
urine proteome of healthy people obtained by non-fixed volume
stepwise elution DEAE-Sephacel anion exchange chromatography. (pI 3-
10NL) (A) Proteins in fraction NaCl-1 obtained by elution with 50
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